Principal Financial Group Inc. raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 7.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 551,924 shares of the company’s stock after acquiring an additional 38,306 shares during the period. Principal Financial Group Inc. owned 0.64% of Pediatrix Medical Group worth $7,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently bought and sold shares of the company. Quest Partners LLC boosted its stake in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares in the last quarter. Quarry LP boosted its stake in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. FMR LLC boosted its stake in Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after acquiring an additional 6,771 shares in the last quarter. Quantinno Capital Management LP acquired a new position in Pediatrix Medical Group in the third quarter valued at $138,000. Finally, SG Americas Securities LLC acquired a new position in Pediatrix Medical Group in the fourth quarter valued at $171,000. Institutional investors and hedge funds own 97.71% of the company’s stock.
Pediatrix Medical Group Trading Down 2.2 %
NYSE MD opened at $14.73 on Friday. The stock has a market capitalization of $1.26 billion, a P/E ratio of -12.28, a P/E/G ratio of 1.74 and a beta of 1.57. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67. The firm has a 50-day moving average price of $13.99 and a 200 day moving average price of $13.17. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on MD. UBS Group upped their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Deutsche Bank Aktiengesellschaft upped their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a report on Monday, November 4th. Truist Financial upped their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. Finally, Mizuho upped their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and an average target price of $17.08.
Get Our Latest Analysis on Pediatrix Medical Group
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also
- Five stocks we like better than Pediatrix Medical Group
- How to invest in marijuana stocks in 7 steps
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- ESG Stocks, What Investors Should Know
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What Are Treasury Bonds?
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.